Correlation Between Neurocrine Biosciences and ANI Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Neurocrine Biosciences and ANI Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neurocrine Biosciences and ANI Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Neurocrine Biosciences and ANI Pharmaceuticals, you can compare the effects of market volatilities on Neurocrine Biosciences and ANI Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neurocrine Biosciences with a short position of ANI Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neurocrine Biosciences and ANI Pharmaceuticals.
Diversification Opportunities for Neurocrine Biosciences and ANI Pharmaceuticals
0.54 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Neurocrine and ANI is 0.54. Overlapping area represents the amount of risk that can be diversified away by holding Neurocrine Biosciences and ANI Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ANI Pharmaceuticals and Neurocrine Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neurocrine Biosciences are associated (or correlated) with ANI Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ANI Pharmaceuticals has no effect on the direction of Neurocrine Biosciences i.e., Neurocrine Biosciences and ANI Pharmaceuticals go up and down completely randomly.
Pair Corralation between Neurocrine Biosciences and ANI Pharmaceuticals
Given the investment horizon of 90 days Neurocrine Biosciences is expected to generate 0.98 times more return on investment than ANI Pharmaceuticals. However, Neurocrine Biosciences is 1.02 times less risky than ANI Pharmaceuticals. It trades about -0.02 of its potential returns per unit of risk. ANI Pharmaceuticals is currently generating about -0.03 per unit of risk. If you would invest 14,048 in Neurocrine Biosciences on August 24, 2024 and sell it today you would lose (1,548) from holding Neurocrine Biosciences or give up 11.02% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Neurocrine Biosciences vs. ANI Pharmaceuticals
Performance |
| Timeline |
| Neurocrine Biosciences |
| ANI Pharmaceuticals |
Neurocrine Biosciences and ANI Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Neurocrine Biosciences and ANI Pharmaceuticals
The main advantage of trading using opposite Neurocrine Biosciences and ANI Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neurocrine Biosciences position performs unexpectedly, ANI Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ANI Pharmaceuticals will offset losses from the drop in ANI Pharmaceuticals' long position.| Neurocrine Biosciences vs. Catalent | Neurocrine Biosciences vs. Amphastar P | Neurocrine Biosciences vs. ANI Pharmaceuticals | Neurocrine Biosciences vs. Alkermes Plc |
| ANI Pharmaceuticals vs. Phibro Animal Health | ANI Pharmaceuticals vs. Prestige Brand Holdings | ANI Pharmaceuticals vs. Alkermes Plc | ANI Pharmaceuticals vs. Dr Reddys Laboratories |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Other Complementary Tools
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |